Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 1
2007 1
2008 2
2010 2
2011 2
2012 2
2013 2
2014 3
2015 9
2016 5
2017 4
2018 3
2019 2
2020 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
FDA Approval: Blinatumomab.
Przepiorka D, Ko CW, Deisseroth A, Yancey CL, Candau-Chacon R, Chiu HJ, Gehrke BJ, Gomez-Broughton C, Kane RC, Kirshner S, Mehrotra N, Ricks TK, Schmiel D, Song P, Zhao P, Zhou Q, Farrell AT, Pazdur R. Przepiorka D, et al. Among authors: mehrotra n. Clin Cancer Res. 2015 Sep 15;21(18):4035-9. doi: 10.1158/1078-0432.CCR-15-0612. Clin Cancer Res. 2015. PMID: 26374073
Neurodegenerative Diseases: The Value of Early Predictive End Points.
Janicki Hsieh S, Alexopoulou Z, Mehrotra N, Struyk A, Stoch SA. Janicki Hsieh S, et al. Among authors: mehrotra n. Clin Pharmacol Ther. 2022 Apr;111(4):835-839. doi: 10.1002/cpt.2544. Epub 2022 Mar 2. Clin Pharmacol Ther. 2022. PMID: 35234294 Review.
FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.
Deisseroth A, Ko CW, Nie L, Zirkelbach JF, Zhao L, Bullock J, Mehrotra N, Del Valle P, Saber H, Sheth C, Gehrke B, Justice R, Farrell A, Pazdur R. Deisseroth A, et al. Among authors: mehrotra n. Clin Cancer Res. 2015 Mar 1;21(5):950-4. doi: 10.1158/1078-0432.CCR-14-1678. Epub 2015 Jan 19. Clin Cancer Res. 2015. PMID: 25601959 Review.
Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium.
Heller S, Darpö B, Mitchell MI, Linnebjerg H, Leishman DJ, Mehrotra N, Zhu H, Koerner J, Fiszman ML, Balakrishnan S, Xiao S, Todaro TG, Hensley I, Guth BD, Michelson EL, Sager P. Heller S, et al. Among authors: mehrotra n. Am Heart J. 2015 Jul;170(1):23-35. doi: 10.1016/j.ahj.2015.03.007. Epub 2015 Mar 18. Am Heart J. 2015. PMID: 26093861 Review.
Identifying and characterising sources of variability in digital outcome measures in Parkinson's disease.
Roussos G, Herrero TR, Hill DL, Dowling AV, L T M Müller M, Evers LJW, Burton J, Derungs A, Fisher K, Kilambi KP, Mehrotra N, Bhatnagar R, Sardar S, Stephenson D, Adams JL, Ray Dorsey E, Cosman J. Roussos G, et al. Among authors: mehrotra n. NPJ Digit Med. 2022 Jul 15;5(1):93. doi: 10.1038/s41746-022-00643-4. NPJ Digit Med. 2022. PMID: 35840653 Free PMC article.
Reporting guidelines for population pharmacokinetic analyses.
Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, Jadhav P, Wang Y, Byon W. Dykstra K, et al. Among authors: mehrotra n. J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):301-14. doi: 10.1007/s10928-015-9417-1. Epub 2015 Apr 30. J Pharmacokinet Pharmacodyn. 2015. PMID: 25925797 Free PMC article.
Reporting guidelines for population pharmacokinetic analyses.
Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, Jadhav P, Wang Y, Byon W. Dykstra K, et al. Among authors: mehrotra n. J Clin Pharmacol. 2015 Aug;55(8):875-87. doi: 10.1002/jcph.532. J Clin Pharmacol. 2015. PMID: 26148467
43 results